Sofwave Medical Ltd (SOFW) - Total Liabilities
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has total liabilities worth ILA22.97 Million ILA (≈ $61.57K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see SOFW current and non-current assets.
Sofwave Medical Ltd - Total Liabilities Trend (2018–2025)
This chart illustrates how Sofwave Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. See SOFW working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Sofwave Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Sofwave Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Xinguang Pharmaceutical Co Ltd
SHE:300519
|
China | CN¥65.46 Million |
|
Ronshin Group A
SHE:301231
|
China | CN¥134.42 Million |
|
Solus Advanced Materials Co Ltd
KO:336370
|
Korea | ₩1.08 Trillion |
|
Wuxi Lihu Corporation Limited Class A
SHE:300694
|
China | CN¥467.00 Million |
|
Shenzhen Wenke Landscape Co Ltd
SHE:002775
|
China | CN¥6.18 Billion |
|
GuangZhou Wahlap Technology Corporation Limited
SHE:301011
|
China | CN¥574.54 Million |
|
Radium Life Tech Co Ltd
TW:2547
|
Taiwan | NT$48.08 Billion |
|
Shanxi C&Y Pharmaceutical Group Co Ltd
SHE:300254
|
China | CN¥1.07 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Sofwave Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check SOFW financial resilience to evaluate the company's liquid asset resilience ratio.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sofwave Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sofwave Medical Ltd (2018–2025)
The table below shows the annual total liabilities of Sofwave Medical Ltd from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA23.06 Million ≈ $61.84K |
+24.65% |
| 2024-12-31 | ILA18.50 Million ≈ $49.61K |
+7.62% |
| 2023-12-31 | ILA17.19 Million ≈ $46.09K |
+25.15% |
| 2022-12-31 | ILA13.74 Million ≈ $36.83K |
-2.34% |
| 2021-12-31 | ILA14.07 Million ≈ $37.71K |
+327.96% |
| 2020-12-31 | ILA3.29 Million ≈ $8.81K |
+55.41% |
| 2019-12-31 | ILA2.12 Million ≈ $5.67K |
+73.79% |
| 2018-12-31 | ILA1.22 Million ≈ $3.26K |
-- |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more